Sandesh Mahatme - Jul 9, 2025 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role: CFO
Signature: /s/ Sherell Bacchas, Attorney-in-Fact
Stock symbol: VOR
Transactions as of: Jul 9, 2025
Transactions value $: $0
Form type: 4
Date filed: 7/10/2025, 04:51 PM
Previous filing: Jun 6, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Mahatme Sandesh	CFO	C/O VOR BIOPHARMA INC., 100 CAMBRIDGEPARK DRIVE, SUITE 101, CAMBRIDGE	/s/ Sherell Bacchas, Attorney-in-Fact	2025-07-10	0001511034

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VOR	Common Stock	Award	$0	+13.9M		$0.00	13.9M	Jul 9, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. 1/4th of the RSUs vest on July 1, 2026, with the remainder vesting in equal quarterly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date.